January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Cutaneous Head and Neck Melanoma: Better Outcomes with ICIs

Explore the distinct clinicopathological features and treatment outcomes of cutaneous head and neck melanoma versus other melanoma sites.

Conexiant

January 15, 2025

Gender and Site-Specific Trends in Melanoma Incidence

Global analysis reveals distinct melanoma patterns by gender and site, with females showing excess lower limb cases.

Conexiant

January 14, 2025

Novel Focal Point Technology Controls Laser Treatment Depth

"The focused ring beam spares an island of superficial tissue," researchers report in a new study demonstrating precise depth control in laser treatments while protecting the epidermis.

Conexiant

January 13, 2025

Vitiligo Treatment: ASCS vs. NB-UVB

Autologous skin cell suspension therapy demonstrates effective and durable repigmentation for stable vitiligo, showing higher repigmentation rates compared to narrow-band ultraviolet B therapy alone.

Conexiant

January 07, 2025

Patient Insights on HRQOL in Chronic GVHD

Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains.

Conexiant

January 07, 2025

New Vitiligo Markers Found in Blood, Tissue

"Based upon the expression levels of miR-16, 146a, 19b and 720 in both serum and tissue, these biomarkers can be used as early indicators for vitiligo."

Conexiant

December 23, 2024

Cancer Drug Side Effect Causes Skin Changes

New research reveals that one-third of cancer patients developed red, inflammatory skin lesions before experiencing vitiligo-like depigmentation from immune checkpoint inhibitor therapy, potentially offering clinicians an early warning sign.

Conexiant

April 30, 2024

Improving Measurement of Postinflammatory Hyperpigmentation With Novel Scale

Researchers have developed a scale to assess postinflammatory hyperpigmentation.

Conexiant